| dc.description.abstract | This study aims to investigate the current status and development strategies of the cancer genetic testing market in Taiwan′s precision medicine industry. Through literature review, in-depth interviews, and case studies, we conducted a comprehensive analysis of the market situation and the challenges faced by Taiwanese companies in a competitive market landscape. The study reveals that cancer genetic testing technology holds significant potential in prevention, early diagnosis, and post-operative monitoring. It is suggested that companies prioritize market demand and explore new market opportunities, such as the cancer prevention market, while leveraging technological innovation and collaboration strategies to tap into blue ocean markets. Taking company P as a case study, we found its success lies in effective utilization of technological innovation, market education, and collaborative promotion. In the future, sustained technological innovation, interdisciplinary collaboration, and supportive market and policy environment will be key factors for the continued development of the cancer genetic testing market. This study provides a comprehensive understanding of the cancer genetic testing market in Taiwan′s precision medicine industry and proposes viable development strategies to contribute to its continuous growth and expansion. | en_US |